Concepedia

Robert VanderWeele

RV

Statistics

Publications

3

Citations

55

H-Index

3

Active since

2016

Affiliations

UPMC Hillman Cancer Center(Current)

Robert VanderWeele is an author at UPMC Hillman Cancer Center specializing in oncology, immunotherapy, and immune checkpoint inhibitors.

Publications per year

2016–2024

3

Publications

3

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab

Janet Retseck, Robert VanderWeele, Hui‐Min Lin et al. · Journal for ImmunoTherapy of Cancer · 2016 · 26 citations · Full text

, , +17

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial

Jennifer L. Steel, Charles J. George, Lauren Terhorst et al. · The Lancet · 2024 · 19 citations · Full text

, , +16

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

Yana G. Najjar, Fei Ding, Yan Lin et al. · Journal of Translational Medicine · 2017 · 10 citations · Full text

, , +17

1–3 of 3